Overview

Bi-Weekly Docetaxel Plus 24-Hour Infusion of High-Dose 5-Fluorouracil / Leucovorin (HDFL) for Inoperable Advanced or Metastatic Gastric Cancer

Status:
Terminated

Trial end date:
2005-07-01

Target enrollment:

Participant gender:

Summary

The primary objective is to determine the tumor response rate of bi-weekly docetaxel plus 24-hour infusion of high-dose 5-FU/leucovorin chemotherapy for patients with inoperable advanced gastric cancer.

Phase:

Phase 2

Details

Lead Sponsor:

National Taiwan University Hospital

Treatments:

Docetaxel
Fluorouracil
Leucovorin